Carcinoma in situ in the Testis

REFERENCES

• Skakkebwk NE. Possible carcinoma-in-situ of the testis. Lancet 1972; ii: 516–7.
   Google Scholar
• Langhans T. Carcinoma testis. In: Kocher T, ed. Krank-heiten der männlichen Geschlechtsorgane. Deutsche Chirurgie, Vol. Lieferung 50B. Stuttgart: Enke, 1887: 438–61.
   Google Scholar
• Wilms M. Die teratoiden Geschwillste des Hodens, mit Einschluss der sog. Cystoide und Enchondrome. Beitr Pathol Anat 1896; 19: 233–366.
   Google Scholar
• Young RH, Scully RE Testicular tumors. Chicago, IL: ASCP Press, 1990: 89–100.
   Google Scholar
• Gondos B, Berthelsen JG, Skakkebwk NE. Intratubular germ cell neoplasia (carcinoma in situ): A preinvasive lesion of the testis. Ann Clin Lab Sci 1983; 13: 185–92.
   Google Scholar
• Grigor KM. A new classification of germ cell tumours of the testis. Eur Urol 1993; 23: 93–103.
   PubMed Web of Science ®Google Scholar
• Loy V, Dieckmann K-P. Carcinoma in situ of the testis: Intratubular germ cell neoplasia or testicular intraepi-thelial neoplasia? Hum Pathol 1990; 21: 457.
   Google Scholar
• Damjanov I. Male reproductive system. In: Damjanov I, Linder J, eds. Anderson's pathology, 10th edn. St. Louis, MO: Mosby, 1996: 2166–230.
   Google Scholar
• Mostofi FK, Sesterhenn IA, Sobin LH World Health Organization International Histological Classification of Tumours: Histological typing of testis tumours, 2nd edn. Berlin: Springer-Verlag, 1998.
   Google Scholar
• Pugh RCB Pathology of the testis. Oxford: Blackwell, 1976.
   Google Scholar
• Talerman A, Fu YS, Okagaki T. Spermatocytic semi-noma. Ultrastructural and microspectrophotometric observations. Lab Invest 1984; 51: 343–9.
   Google Scholar
• Dekker I, Rozeboom T, Delemarre J, Dam A, Oosterhuis JVV. Placental-like alkaline phosphatase and DNA flow cytometry in spermatocytic seminoma. Cancer 1992; 69: 993–6.
   Google Scholar
• Guinand S, Hedinger C. Atypical intratubular germ cells and testicular germ cell tumors in children. Ann Pathol 1981; 1: 251–7 (in French).
   PubMed Web of Science ®Google Scholar
• Manivel JC, Simonton S, Wold LE, Dehner LP. Absence of intratubular germ cell neoplasia in testicular yolk sac tumors in children. A histochemical and immunohistochemical study. Arch Pathol Lab Med 1988; 112: 641–5.
   Google Scholar
• Stock C, Strehl S, Fink FM, Bauer S, Lion T, Kreczy A, et al. Isochromosome 12p and maternal loss of 1p36 in a pediatric testicular germ cell tumor. Cancer Genet Cytogenet 1996; 91: 95–100.
   PubMedGoogle Scholar
• Holstein AF, Schinte B, Becker H, Hartmann M. Morphology of normal and malignant germ cells. Int J Androl 1987; 10: 1–18.
   PubMedGoogle Scholar
• Albrechtsen R, Nielsen MH, Skakkebwk NE, Wewer U. Carcinoma in situ of the testis. Some ultrastructural characteristics of germ cells. APMIS 1982; 90: 301–3.
   Google Scholar
• Gondos B. Ultrastructure of developing and malignant germ cells. Eur Urol 1993; 23: 68–75.
   PubMed Web of Science ®Google Scholar
• Muller J, Skakkebwk NE. Microspectrophotometric DNA measurements of carcinoma-in-situ germ cells in the testis. Int J Androl 1981; 4(Suppl.): 211–21.
   Google Scholar
• De Graaff W, Oosterhuis JW, De Jong B, Dam A, Van Putten WLJ, Castedo SMMJ, et al. Ploidy of testicular carcinoma in situ. Lab Invest 1992; 66: 166–8.
   PubMed Web of Science ®Google Scholar
• Milken K, Lauke H. Mitotic frequency in different early stages of testicular seminoma. Andrologia 1996; 28: 335–41.
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Lauke H, Skakkebwk NE. In vitro survival of human neoplastic germ cells. Adv Exp Med Biol 1999; 444: 59–66.
   Google Scholar
• Walt H, Emmerich P. Cremer T, Hofmann MC, Bannwart F. Supernumerary chromosome 1 in inter-phase nuclei of atypical germ cells in paraffin-embedded human seminiferous tubules. Lab Invest 1989; 61: 527–31.
   Google Scholar
• Looijenga LHJ, Gillis AJM, van Pullen WLJ, Ooster-huis JVV. In situ numeric analysis of centromeric regions of chromosomes 1, 12, and 15 of seminomas, nonseminomatous germ cell tumours, and carcinoma in situ of human testis. Lab Invest 1993; 68: 211–9.
   Google Scholar
• Rajpert-De Meyts E, Kvist M, Skakkebwk NE. Hetero-geneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance. Virchows Arch 1996; 428: 133–9.
   Google Scholar
• Atkin NB, Baker MC. Specific chromosome change, i(12p), in testicular tumours? Lancet 1982; ii: 1349.
   Google Scholar
• Geurts van Kessel A, Suijkerbuijk RF, Sinke RJ, Looijenga L, Oosterhuis JVV, de Jong B. Molecular cytogenetics of human germ cell tumours: i(12p) and related chromosomal anomalies. Eur Urol 1993; 23: 23–9.
   Web of Science ®Google Scholar
• Geurts van Kessel A, van Drunen E, de Jong B, Oosterhuis JVV, Langeveld A, Mulder MP. Chromo-some 12q heterozygosity is retained in i(12p)-positive testicular germ cell tumour cells. Cancer Genet Cytogenet 1989; 40: 129–34.
   PubMedGoogle Scholar
• Vos A, Oosterhuis JVV, de Jong B, Buist J, Schraffordt Koops H. Cytogenetics of carcinoma in situ of the testis. Cancer Genet Cytogenetics 1990; 48: 143–67.
   PubMedGoogle Scholar
• Van Echten J, Van Gurp RJHLM, Stoepker M, Looijenga LHJ, De Jong B, Oosterhuis JVV. Cytogenetic evidence that carcinoma in situ is the precursor lesion for invasive testicular germ cell tumours. Cancer Genet Cytogenet 1995; 85: 133–7.
   PubMedGoogle Scholar
• Lehmann D, Temminck B, Litmanen K, Leibundgut B, Hadziselimovic F, Milner H. Autoimmune phenomena and cytogenetic findings in a patient with carcinoma (seminoma) in situ. Cancer 1986; 58: 2013–7.
   PubMed Web of Science ®Google Scholar
• Vorechovsky I, Mazanec K. Cytogenetic investigation of gonadal carcinomas in situ in syndromes of abnormal sexual differentiation. Recent Results Cancer Res 1991; 123: 45–9.
   PubMedGoogle Scholar
• Chaganti RSK, Houldsworth J. The cytogenetic theory of the pathogenesis of human adult male germ cell tumours. APMIS 1998; 106: 80–4.
   PubMed Web of Science ®Google Scholar
• Looijenga LHJ, Rosenberg C, Van Gurp RJHLM, Geelen E, Van Echten-Arends J, De Jong B, et al. Comparative genomic hybridization of microdissected samples from different stages in the development of a seminoma and nonseminoma. J Pathol 2000; 191: 187–92.
   Google Scholar
• Roelofs H, Mostert MMC, Pompe K, Zafarana G, Van Oorschot M, Van Gurp R, et al. Role of restricted 12p-amplification and RAS mutation in the development and clinical behaviour of human testicular germ cell tumors of adolescents and adults. Am J Pathol 2000: in press.
   Google Scholar
• Korn MW, Olde Weghuis DEM, Suijkerbuijk RF, Schmidt U, Otto T, Du Manoir S, et al. Detection of chromosomal DNA gains and losses in testicular germ cell tumors by comparative genomic hybridization. Genes Chromosomes Cancer 1996; 17: 78–87.
   PubMed Web of Science ®Google Scholar
• Ottesen AM, Kirchhoff M, Rajpert De-Meyts E, Maahr J, Gerdes T, Rose H, et al. Detection of chromosomal aberrations in seminomatous germ cell tumours using comparative genomic hybridization. Genes Chromo-somes Cancer 1997; 20: 412–8.
   Google Scholar
• Summersgill B, Goker H, Weber-Hall S, Huddart R, Horwich A, Shipley J. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br J Cancer 1998; 77: 305–13.
   Google Scholar
• Sandberg AA, Meloni AM, Suijkerbuijk RF. Reviews of chromosome studies in urological tumors.3. Cyto-genetics and genes in testicular tumors. J Urol 1996; 155: 1531–56.
   Google Scholar
• Olie RA, Looijenga LHJ, Dekker MC, De Jong FH, De Rooy DG, Oosterhuis JVV. Heterogeneity in the in vitro survival and proliferation of human seminoma cells. Br J Cancer 1995; 71: 13–7.
   Google Scholar
• Olie RA, Boersman AWM, Dekker MC, Nooter K, Looijenga LHJ, Oosterhuis JVV. Apoptosis of human seminoma cells upon disruption of their micro-environ-ment. Br J Cancer 1996; 73: 1031–6.
   PubMed Web of Science ®Google Scholar
• Looijenga LHJ, Oosterhuis JVV. Pathogenesis of testicular germ cell tumors. Rev Reprod 1999; 4: 90–100.
   PubMedGoogle Scholar
• Hofmann MC, Milian JL. Developmental expression of alkaline phosphatase genes; reexpression in germ cell tumours and in vitro immortalized germ cells. Eur Urol 1993; 23: 38–44.
   PubMed Web of Science ®Google Scholar
• Roelofs H, Manes T, Milian JL, Oosterhuis JVV, Looijenga LHJ. Heterogeneity in alkaline phosphatase isozyme expression in human testicular germ cell tumors. An enzyme-/immunohistochemical and mol-ecular analysis. J Pathol 1999; 189: 236–44.
   Google Scholar
• Hustin J, Collette J, Franchimont P. Immunohistochem-ical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl 1987; 10: 29–35.
   Google Scholar
• Jorgensen N, Rajpert-De Meyts E, Grwm N, Muller J, Giwereman A, Skakkebaek NE. Expression of immu-nohistochemical markers for testicular carcinoma in situ by normal human foetal germ cells. Lab Invest 1995; 72: 223–31.
   PubMed Web of Science ®Google Scholar
• Wahren B, Holmgren PA, Stigbrand T. Placental alkaline phosphatase, alphafetoprotein and carcinoem-bryonic antigen in testicular tumors. Int J Cancer 1979; 24: 749–53.
   Google Scholar
• Beckstead JH. Alkaline phosphatase histochemistry in human germ cell neoplasms. Am J Surg Pathol 1983; 7: 341–9.
   PubMed Web of Science ®Google Scholar
• Jacobsen GK, Norgaard-Pedersen B. Placental alkaline phosphatase in testicular germ cell tumours and in carcinoma-in-situ of the testis. Acta Pathol Microbiol Scand A 1984; 92: 323–9.
   Google Scholar
• Koide O, Iwai S, Baba K, In H. Identification of testicular atypical germ cells by an immunohisto-chemical technique for placental alkaline phosphatase. Cancer 1987; 60: 1325–30.
   PubMed Web of Science ®Google Scholar
• Manivel JC, Jessurun J, Wick MR, Dehner LP. Placental alkaline phosphatase immunoreactivity in tes-ticular germ-cell neoplasms. Am J Surg Pathol 1987; 11: 21–9.
   PubMed Web of Science ®Google Scholar
• Burke AP, Mostofi FK. Intratubular malignant germ cells in testicular biopsies: Clinical course and identi-fication by staining for placental alkaline phosphatase. Mod Pathol 1988; 1:475–9.
   PubMed Web of Science ®Google Scholar
• Burke AP, Mostofi FK. Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol 1988; 19: 663–70.
   PubMed Web of Science ®Google Scholar
• Hofmann MC, Jeltsch W, Brecher J, Walt H. Alkaline phosophatase isozymes in human testicular germ cell tumors, their precancerous stage, and three related cell lines. Cancer Res 1989; 49: 4696–700.
   PubMed Web of Science ®Google Scholar
• Giwereman A, Cantell L, Marks A. Placental-like alkaline phosphatase as a marker of carcinoma in situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F. APMIS 1991; 99: 586–94.
   Google Scholar
• Yarden Y, Kuang W-J, Yang-Feng T, Coussens L, Munemitsu S, Dull TJ, et al. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand. EMBO J 1987; 6: 3341–51.
   Google Scholar
• Chabot B, Stephenson DA, Chapman VM, Besmer P. Bernstein A. The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 1988; 335: 88–9.
   Google Scholar
• Manova K, Nocka K, Besmer P. Bachvarova RF. Gonadal expression of c-kit encoded at the W locus of the mouse. Development 1990; 110: 1057–69.
   Google Scholar
• Manova K, Bachvarova RF. Expression of c-kit encoded at the W locus of mice in developing embryonic germ cell and presumptive melanoblasts. Dev Biol 1991; 146: 312–24.
   PubMed Web of Science ®Google Scholar
• Keshet E, Lyman SD, Williams DE, Anderson DM, Jenkins NA, Copeland NG, et al. Embryonic RNA expression patterns of the c-kit receptor and its cognate ligand suggest multiple functional roles in mouse development. EMBO J 1991; 10: 2425–35.
   PubMed Web of Science ®Google Scholar
• Hone K, Fujita J, Takakura H, Kanzaki H, Suginami H, Iwai M, et al. The expression of c-kit protein in human adult and fetal tissues. Hum Reprod 1993; 8: 1955–62.
   PubMed Web of Science ®Google Scholar
• Strohmeyer T, Reese D, Press M, Ackerman R, Hartmann M, Slamon D. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 1995; 153: 511–5.
   PubMed Web of Science ®Google Scholar
• Strohmeyer T, Peter S, Hartmann M, Munemitsu S, Ackerman R, Ullrich A, et al. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res 1991; 51: 1811–6.
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Skakkebwk NE. Expression of the c-kit protein product in carcinoma in situ and invasive germ cell tumours. Int J Androl 1994; 17: 85–92.
   Google Scholar
• Shinohara T, Orwig KE, Avarbock MR, Brinster R. Spermatogonial stem cell enrichment by multipar-ameter selection of mouse testis cells. Proc Natl Acad Sci USA 2000; 97: 8346–51.
   PubMed Web of Science ®Google Scholar
• Izquierdo MA, Van der Valk P, Van Ark-Otte J, Rubio G, Germa-Lluch JR, Ueda R, et al. Differential expression of the c-kit proto-oncogene in germ cell tumours. J Pathol 1995; 177: 253–8.
   Google Scholar
• Bokemeyer C, Kuczyk MA, Dunn T, Serth J, Hartmann K, Jonasson J, et al. Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. J Cancer Res Clin Oncol 1996; 122: 301–6.
   PubMed Web of Science ®Google Scholar
• Tian Q, Frierson Jr HF, Krystal GW, Moskaluk CA. Activating c-kit gene mutations in human germ cell tumors. Am J Pathol 1999; 154: 1643–.
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Jorgensen N, Muller J, Skakkebwk NE. Prolonged expression of the c-kit receptor in germ cells of intersex fetal testes. J Pathol 1996; 178: 166–9.
   Google Scholar
• Rajpert-De Meyts E, Jorgensen N, Brondum-Nielsen K, Muller J, Skakkebwk NE. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 1998; 106: 198–206.
   Google Scholar
• Kawata M, Seikya S, Hatekeyama R, Takamizawa H. Neuron-specific enolase as a serum marker for immature teratoma and dysgerminoma. Gynecol Oncol 1989; 32: 191–7.
   PubMed Web of Science ®Google Scholar
• Fossi SD, Klepp O, Paus E. Neuron-specific enolase-a serum tumour marker in seminoma? Br J Cancer 1992; 65: 297–9.
   Google Scholar
• Kang J-L, Rajpert-De Meyts E, Skakkebwk NE. Immunoreactive neuron-specific enolase (NSE) is expressed in testicular carcinoma in situ. J Pathol 1996; 178: 161–5.
   PubMed Web of Science ®Google Scholar
• Klys HS, Whillis D, Howard G, Harrison DJ. Gluta-thione S-transferase expression in the human testis and testicular germ cell neoplasia. Br J Cancer 1992; 66: 589–93.
   PubMed Web of Science ®Google Scholar
• Henderson C, McLaren AW, Moffat G, Bacon E, Wolf C. Pi-class glutathione-S-transferase: regulation and function. Chem Biol Interact 1998; 111: 69–82.
   PubMed Web of Science ®Google Scholar
• Hadziselimovic F, Herzog B, Emmons LR. The expression of CD44 adhesion molecules on seminoma cells. A new marker for early detection of the tumor. Cancer 1995; 77: 429–30.
   Google Scholar
• Hadziselimovic F, Herzog B, Emmons LR. The incidence of seminoma and expression of cell adhesion molecule CD44 in cryptorchid boys and infertile men. J Urol 1997; 157: 1895–7.
   Google Scholar
• Miyake H, Hara I, Yamanaka K, Gohji K, Arakawa S, Kamidono S. Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes. Am J Pathol 1998; 152: 1157–60.
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Skakkebwk NE. The expression of CD44 adhesion molecules on seminoma cells. A new marker for early detection of the tumour [letter]. Cancer 1996; 78: 2443–5.
   Google Scholar
• Malmi R, Söderström K-0. Lectin binding to carcino-ma-in situ cells of the testis. Virchows Archiv A: Pathol Anat 1988; 413: 69–75.
   Web of Science ®Google Scholar
• Kang J-L, Rajpert-De Meyts E, Wiels J, Skakkebwk NE. Expression of the glycolipid globotriaosylceramide (Gb3) in testicular carcinoma in situ. Virchows Arch 1995; 426: 369–74.
   PubMed Web of Science ®Google Scholar
• Drescher B, Lauke H, Hartmann M, Davidoff MS, Zumkeller W. Immunohistochemical pattern of insulin-like growth pattern (IGF) I, IGF II, and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. J Clin Pathol: Mol Pathol 1997; 50: 298–303.
   Google Scholar
• Bailey D, Baumal R, Law J, Sheldom K, Kannampuzha P. Stratis M, et al. Production of monoclonal antibody specific for seminomas and dysgerminomas. Proc Natl Acad Sci USA 1986; 83: 5291–5.
   PubMed Web of Science ®Google Scholar
• Giwereman A, Marks A, Bailey D, Baumal R, Skakkebaek NE. A monoclonal antibody as a marker for carcinoma in situ germ cells of the human adult testis. APMIS 1988; 96: 667–70.
   Google Scholar
• Pettijohn DE, Stranahan P, Due C, Ronne E, Sorensen HR, Olsson L. Glycoproteins distinguishing non-small cell from small cell human lung carcinoma recognized by monoclonal antibody 43-9F. Cancer Res 1987; 47: 1161–9.
   PubMed Web of Science ®Google Scholar
• Giwereman A, Lindenberg S, Kimber SJ, Andersson T, Muller J, Skakkebaek NE. Monoclonal antibody 43-9F as a sensitive immunohistochemical marker of carci-noma in situ of human testis. Cancer 1990; 65: 1135–42.
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JVV. Immunohistochemical expression of monoclonal anti-body 43-9F in testicular germ cell tumours. Int J Androl 1998; 21: 283–8.
   PubMedGoogle Scholar
• Andrews PW, Banting GS, Damjanov I, Arnaud D, Avner P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma 1984; 3: 347–61.
   Google Scholar
• Badcock G, Pigott C, Goepel J, Andrews P. The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res 1999; 59: 4715–9.
   PubMed Web of Science ®Google Scholar
• Giwereman A, Andrews PW, Jorgensen N, Muller J, Grwm N, Skakkebaek NE. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis. Cancer 1993; 72: 1308–14.
   PubMed Web of Science ®Google Scholar
• Mosselman S, Claesson-Welsh L, Kamphuis JS, Van Zoelen EJJ. Developmentally regulated expression of two novel platelet-derived growth factor cc-receptor transcripts in human teratocarcinoma cells. Cancer Res 1994; 54: 220–5.
   PubMed Web of Science ®Google Scholar
• Mosselman S, Looijenga LHJ, Gillis AJM, Van Rooijen MA, Kraft HJ, Van Zoelen Ell, et al. Aberrant platelet-derived growth factor cc-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis. Proc Natl Acad Sci USA 1996; 93: 2884–8.
   Google Scholar
• Oosterhuis JVV, Gillis AJM, Van Roozendaal CEP, Van Zoelen Ell, Looijenga LHJ. The platelet-derived growth factor cc-receptor 1.5 kb transcript: target for molecular detection of testicular germ cell tumours of adolescents and adults. APMIS 1998; 106: 207–15.
   Google Scholar
• Herbst H, Sauter M, Mueller-Lantzsch N. Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol 1996; 149: 1727–35.
   Google Scholar
• Herbst H, Sauter M, Kithler-Obbarius C, Löning T, Mueller-Lantzsch N. Human endogenous retrovirus (HERV)-K transcripts in germ cell and trophoblastic tumours. APMIS 1998; 106: 216–20.
   Google Scholar
• Roelofs H, Van Gurp RJLM, Oosterhuis JVV, Looijenga LHJ. Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cel tumors of adolescents and adults; clinical and biological implications. Am J Pathol 1998; 153: 1277–82.
   PubMed Web of Science ®Google Scholar
• Bartkova J, Bartek J, Lukas J, Vojtesek B, Staskova Z, Rejthar A, et al. P53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer 1991; 48: 196–202.
   Web of Science ®Google Scholar
• Kuczyk MA, Serth J, Bokemeyer C, Jonassen J, Machtens S, Werber M, Jonas U. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis. Cancer 1996; 8: 1958–66.
   Google Scholar
• Heidenreich A, Schenkman NS, Sesterhenn IA, Mostofi KF, Moul JVV, Srivastava S, et al. Immunohistochem-ical and mutational analysis of the p53 tumour suppressor gene and the bc1-2 oncogene in primary testicular germ cell tumours. APMIS 1998; 106: 90–
   PubMed Web of Science ®Google Scholar
• Heimdal K, Lothe RA, Lystad S, Holm R, Fossa. SD, Borresen A-L. No germline TP 53 mutations detected in familial and bilateral testicular cancer. Genes Chromo-somes Cancer 1993; 6: 92–7.
   Google Scholar
• Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbui M, et al. Mutations of the p53 gene do not occur in testis cancer. Cancer Res 1993; 53: 3574–8.
   PubMed Web of Science ®Google Scholar
• Chresta CM, Masters JRW, Hickman JA. Hypersensi-tivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and high bax:bc1-2 ratio. Cancer Res 1996; 56: 834–41.
   Google Scholar
• Lutzker SG. Regulation of tumour suppressor activity in teratocarcinoma cells. APMIS 1998; 106: 85–9.
   PubMed Web of Science ®Google Scholar
• Houldsworth J, Xiao H, Murty VVVS, Chen W, Ray B, Reuter VE, et al. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene 1998; 18: 2345–9.
   Web of Science ®Google Scholar
• Burger H, Nooter K, Boersma AWM, van Wingerden KE, Looijenga LHJ, Jochemsen AG, et al. Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines. Int J Cancer 1999; 81: 620–8.
   Google Scholar
• Strohmeyer T, Reissmann P. Cordon-Cardo C, Hart-mann M, Ackermann R, Slamon D. Correlation between retinoblastoma gene expression and differen-tiation in human testicular tumors. Proc Natl Acad Sci USA 1991; 88: 6662–6.
   Google Scholar
• Houldsworth J, Reuter V, Bost GJ, Chaganti RSK. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ 1997; 8: 293–9.
   PubMedGoogle Scholar
• Bartkova J, Rajpert-De Meyts E, Skakkebwk NE, Bartek J. D-type cyclins in adult human testis and testicular cancer: Relation to cell type, proliferation, differentiation, and malignancy. J Pathol 1999; 187: 573–81.
   PubMed Web of Science ®Google Scholar
• Mostert MC, Verkerk AJMH, van de Pol M, Heighway J, Marynen P, Rosenberg C, et al. Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults. Oncogene 1998; 16: 2617–27.
   Google Scholar
• Bartkova J, Thulberg M, Rajpert-De Meyts E, Skakke-bwk NE, Bartek J. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene 2000; 19: 4146–9.
   Google Scholar
• Chaubert P. Guillou L, Kurt A-M, Bertholet M-M, Metthez G, Leisinger H-J, et al. Frequent p16INK4 (MTS1) gene inactivation in testicular germ cell tumors. Am J Pathol 1997; 151: 859–65.
   Google Scholar
• Heidenreich A, Gaddipati JP, Moul JVV, Srivastava S. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumours. J Urol 1998; 159: 1725–30.
   PubMed Web of Science ®Google Scholar
• Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebwk NE, Bartek J. Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours. Int J Cancer 2000; 85: 370–5.
   Google Scholar
• Rapley E, Crockford GP, Teare D, Biggs P, Seal S, Barfoot R, et al. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nature Genet 2000; 24: 197–200.
   PubMed Web of Science ®Google Scholar
• Peng HQ, Liu L, Goss PE, Bailey D, Hogg D. Chromosomal deletions occur in restricted regions of 5q in testicular germ cell cancer. Oncogene 1999; 18: 3277–83.
   Google Scholar
• Bouras M, Tabone E, Bertholon J, Sommer P. Bouvier R, Droz JP, et al. A novel SMAD4 mutation in semi-noma germ cell tumours. Cancer Res 2000; 60: 922–8.
   PubMed Web of Science ®Google Scholar
• Skakkebwk NE, Berthelsen JG, Giwereman A, Muller J. Carcinoma in situ of the testis. Possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987; 10: 19–28.
   Google Scholar
• Van Gurp RJHLM, Oosterhuis JVV, Kalscheuer V, Mariman ECM, Looijenga LHJ. Human testicular germ cell tumours show biallelic expression of the H19 and IGF2 gene. J Natl Cancer Inst 1994; 86: 1070–5.
   Google Scholar
• Looijenga LHJ, Verkerk AJMH, Dekker MC, Van Gurp RJHLM, Gillis AJM, Oosterhuis W. Genomic imprint-ing in testicular germ cell tumours. APMIS 1998; 106: 187–97.
   Google Scholar
• Sell S, Pierce B. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 1994; 70: 6–22.
   PubMed Web of Science ®Google Scholar
• Sohval AR. Testicular dysgenesis in relation to neo-plasm of the testicle. J Urol 1956; 75: 285–91.
   PubMed Web of Science ®Google Scholar
• Kliesch S, BehreHertle L, Bergmann M.Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes. J Urol 1998; 160: 1894–8.
   Google Scholar
• Skakkebwk NE, Rajpert-De Meyts E, Jorgensen N, Carlsen E, Petersen PM, Giwereman A, et al. Germ cell cancer and disorders of spermatogenesis: An environ-mental connection? APMIS 1998; 106: 3–12.
   PubMed Web of Science ®Google Scholar
• Rajpert-De Meyts E, Skakkebwk NE. The possible role of sex hormones in the development of testicular cancer. Eur Urol 1993; 23: 54–9.
   Google Scholar
• Oosterhuis JVV, Castedo SMMJ, De Jong B, Comelisse CJ, Dam A, Sleijfer DT, et al. Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab Invest 1989; 60: 14–20.
   PubMed Web of Science ®Google Scholar
• Oosterhuis JM, Looijenga LHJ. The biology of human germ cell tumours: retrospective speculations and new prospectives. Eur Urol 1993; 23: 245–50.
   PubMed Web of Science ®Google Scholar
• Chaganti RSK, Murty VVVS, Bost GJ. Molecular genetics of male germ cell tumors. In: Vogelzang NJ, Scardino NJ, Shipley PT, Coffey WV, eds. Compre-hensive textbook of genitourinary oncology. Baltimore, MD: Williams & Wilkins, 1996: 932–40.
   Google Scholar
• Scully RE. Neoplasia associated with anomalous sexual development and abnormal sex chromosomes. Pediatr Adolesc Endocrinol 1981; 8: 203–17.
   Google Scholar
• Milner J, Skakkebaek NE. Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome. Br Med J 1984; 288: 1419–20.
   Web of Science ®Google Scholar
• Cassio A, Cacciari EA, Balsamo A, Grigioni FW, Pascucci MG, Bacci F, et al. Incidence of intratubular germ cell neoplasia in androgen insensitivity syndrome. Acta Endocrinol (Copenh) 1990; 123: 416–22.
   PubMedGoogle Scholar
• Ramani P. Yeung CK, Habeebu SS. Testicular infra-tubular germ cell neoplasia in children and adole-scents with intersex. Am J Surg Pathol 1993; 17: 1124–33.
   Google Scholar
• Blumer CF, Hedinger C. Vorkommen von Keimzellen in adulten kryptorchen Hoden. Pathologe 1989; 10: 3–11.
   PubMed Web of Science ®Google Scholar
• Muller J, Skakkebwk NE, Nielsen OH, Grwm N. Cryptorchidism and testis cancer. Atypical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood. Cancer 1984; 54: 629–34.
   Google Scholar
• Depue RH, Pike MC, Henderson BE. Birth weight and the risk of testicular cancer. JNatl Cancer Inst 1986; 77: 829–30.
   PubMedGoogle Scholar
• Moller H, Prener A, Skakkebwk NE. Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy and genital malformations: case-control studies in Den-mark. Cancer Causes Control 1997; 7: 264–74.
   Google Scholar
• Brown LM, Pottem LM, Hoover RN. Testicular cancer in young men: the search for causes of the epidemic increase in the United States. J Epidemiol Commun Health 1987; 41: 349–54.
   Google Scholar
• Adami H, Bergstrom R, Wilmer M, Zatonski W, Storm H, Ekbom A, et al. Testicular cancer in nine northern European countries. Int J Cancer 1994; 59: 33–8.
   PubMed Web of Science ®Google Scholar
• Hoff Wanderis E, Tretli S, Fossa. SD. Trends in incidence of testicular cancer in Norway 1955–1992. Eur J Cancer 1995; 31A: 2044–8.
   Google Scholar
• Bergstrom R, Adami HO, Wilmer M, Zatonski W, Storm H, Tretli S, et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J Natl Cancer Inst 1996; 88: 727–33.
   PubMed Web of Science ®Google Scholar
• McKieman JM, Goluboff ET, Liberson GL, Golden R, Fisch H. Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 1999; 162: 361–3.
   Google Scholar
• Moller H. Decreased testicular cancer risk in men born in wartime [letter]. J Natl Cancer Inst 1989; 81: 1668–9.
   PubMedGoogle Scholar
• Toppari J, Larsen JC, Christiansen P. Giwereman A, Grandjean P. Guillette LJ, et al. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 1996; 104(Suppl 4): 741–803.
   PubMed Web of Science ®Google Scholar
• Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983; 71: 1151–5.
   PubMed Web of Science ®Google Scholar
• Yasuda Y, Kihaja T, Tamimura T. Gonadal dysgenesis induced by prenatal exposure to ethinyl estradiol in mice. Teratology 1985; 32: 210–29.
   Google Scholar
• Kelce WR, Lambright CR, Gray Jr LE, Roberts KP. Vinclozolin and p,p'-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol Appl Pharma-col 1997; 142: 192–200.
   PubMed Web of Science ®Google Scholar
• Bannwart FB, Sigg C, Hedinger C. Morphologie, Biologie und therapeutische Konsequenzen der aty-pischen Keimzellen des Hodens. Zbl Haut 1988; 154: 861–6.
   Google Scholar
• Schate B, Holstein AF, Schirren C. Macrophages lysing seminoma cells in patients with carcinoma-in-situ (CIS) of the testis. Andrologia 1988; 20: 295–303.
   Google Scholar
• Skakkebwk NE. Atypical germ cells in the adjacent "normal" tissue of testicular tumours. Acta Pathol Microbiol Scand A 1975; 83: 127–30.
   PubMedGoogle Scholar
• Jacobsen GK, Henriksen OB, von der Maase H. Carcinoma in situ of testicular tissue adjacent to malig-nant germ-cell tumors: a study of 105 cases. Cancer 1981; 47: 2660–2.
   Google Scholar
• Sigg C, Hedinger C. Keimzelltumoren des Hodens und atypische Keimzellen. Schweiz Med Wochenschr 1980; 110: 801–6.
   PubMedGoogle Scholar
• Loftus BM, Gilmartin LG, O'Brien MJ, Carney DN, Dervan PA. Intratubular germ cell neoplasia of the testis: Identification by placental alkaline phosphatase immunostaining and argyrophilic nucleolar organizer region quantification. Hum Pathol 1990; 21: 941–8.
   Google Scholar
• Loy V. Wigand I, Dieckmann K-P. Incidence and distribution of carcinoma in situ in testes removed for germ cell tumour: possible inadequacy of random testicular biopsy in detecting the condition. Histo-pathology 1990; 16: 198–200.
   Google Scholar
• Soosay GN, Bobrow L, Happerfield L, Parkinson MC. Morphology and immunohistochemistry of carcinoma in situ adjacent to testicular germ cell tumours in adults and children: implications for histogenesis. Histo-pathology 1991; 19: 537–44.
   Google Scholar
• Herr HVV, Sheinfeld J. Is biopsy of the contralateral testis necessary in patients with germ cell tumors? J Urol 1997; 158: 1331–4.
   PubMed Web of Science ®Google Scholar
• Bruun E, Frimodt-Moller C, Giwereman A, Lenz S, Skakkebwk NE. Testicular biopsy as an outpatient procedure in screening for carcinoma in situ: complications and the patient's acceptance. Int J Androl 1987; 10: 199–202.
   PubMedGoogle Scholar
• Gordon DL, Barr AB, Herrigel JE, Paulsen CA. Testicular biopsy in man. I. Effect upon sperm con-centration. Fertil Steril 1965; 16: 522–30.
   PubMed Web of Science ®Google Scholar
• Rowley MJ, O'Keefe KB, Heller CG. Decrease in sperm concentration due to testicular biopsy procedure in man. J Urol 1969; 101: 347–9.
   PubMed Web of Science ®Google Scholar
• Hjort T, Linnet L, Skakkebwk NE. Testicular biopsy: Indications and complications. Eur J Pediatr 1982; 138: 23–5.
   Google Scholar
• Berthelsen JG, Skakkebaek NE. Value of testicular biopsy in diagnosing carcinoma in situ testis. Scand J Urol Nephrol 1981; 15: 165–8.
   PubMed Web of Science ®Google Scholar
• Dieckmann K-P, Souchon R, Hahn E, Loy V. False-negative biopsies for testicular intraepithelial neoplasia. J Urol 1999; 162: 364–8.
   Google Scholar
• Heikkila R, Heilo A, Stenwig AE, Fossa SD. Testicular ultrasonography and 18G biopsy for clinically un-detected cancer or carcinoma in situ in patients with germ cell tumours. Br J Urol 1993; 71: 214–6.
   PubMedGoogle Scholar
• Nagler BM, Kaufman DG, O'Toole KM, Sawczuk IS. Carcinoma in situ of the testes: diagnosis by aspiration flow cytometry. J Urol 1990; 143: 359–61.
   Google Scholar
• Harrington TG, Schauer D, Gilbert BR. Percutaneous testis biopsy: an alternative to open testicular biopsy in the evaluation of the subfertile mean. J Urol 1996; 156: 1647–51.
   Google Scholar
• Harland SJ, Cook PA, Fossa SD, Horwich A, Mead GM, Parkinson MC, et al. Intratubular germ cell neoplasia of the contralateral testis in testicular cancer: Defining a high risk group. J Urol 1998; 160: 1353–7.
   PubMed Web of Science ®Google Scholar
• Rowley MJ, Heller CG. The testicular biopsy: Surgical procedure, fixation and staining technics. Fertil Steril 1966; 17: 177–86.
   PubMed Web of Science ®Google Scholar
• Nistal M, Paniagua R. Testicular biopsy. Contemporary interpretation. Urol Clin N Am 1999; 26: 555–93.
   PubMed Web of Science ®Google Scholar
• Laczkó J, Levai G. A simple differential staining method for semi-thin sections of ossifying cartilage and bone tissues embedded in epoxy resin. Mikroskopie 1975; 31: 1–4.
   Google Scholar
• Milner M, Lauke H, Hartmann M. The value of the AgNOR staining method in identifying carcinoma in situ testis. Pathol Res Pract 1994; 190: 429–35.
   Google Scholar
• Meng FJ, Giwereman A, Skakkebwk NE. Investigation of CIS cells by quantification of argyrophilic nucleolar organizer region associated proteins (AgNORs). J Pathol 1996; 180: 206–13.
   Google Scholar
• Lenz S, Giwereman A, Skakkebaek NE, Bruun E, Frimodt-Moller C. Ultrasound in detection of early neoplasia of the testis. Int J Androl 1987; 10: 187–90.
   Google Scholar
• Kragel PJ, Delvecchio D, Orlando R, Garvin DF. Ultrasonographic findings of testicular microlithiasis associated with intratubular germ cell neoplasia. Urology 1991; 37: 66–8.
   PubMed Web of Science ®Google Scholar
• Backus ML, Mack LA, Middleton WD, King BF, Winter TC, True LD. Testicular microlithiasis: imaging appearances and pathologic correlation. Radiology 1994; 192: 781–5.
   PubMed Web of Science ®Google Scholar
• Ganem JP, Workman KR, Shaban SF. Testicular microlithiasis is associated with testicular pathology. Urology 1999; 53: 209–13.
   Google Scholar
• Lenz S, Skakkebaek NE, Hertel NT. Abnormal ultra-sonic pattern in contralateral testes in patients with unilateral testicular cancer. World J Urol 1996; 14: S55–8.
   Google Scholar
• Kang J-L, Rajpert-De Meyts E, Giwereman A, Skakkebwk NE. The association of testicular carcinoma in situ with intratubular microcalcifications. J Urol Pathol 1994; 2: 235–42.
   Google Scholar
• Giwereman A, Marks A, Skakkebwk NE. Carcinoma-in-situ germ cells exfoliated from seminiferous epithe-IMm into seminal fluid. Lancet 1988; i: 530.
   Google Scholar
• Meng FJ, Zhou Y, Skakkebwk NE, Giwereman A. Detection and enrichment of carcinoma-in-situ cells in semen by an immunomagnetic method using mono-clonal antibody M2A. Int J Androl 1996; 19: 365–70.
   PubMedGoogle Scholar
• Giwereman A, Hopman AGH, Ramaekers FCS, Skakkebwk NE. Carcinoma in situ of the testis. Detection of malignant germ cells in seminal fluid by means of in situ hybridization. Am J Pathol 1990; 136: 497–502.
   Google Scholar
• Meng FJ, Zhou Y, Giwereman A, Skakkebaek NE, Geurts van Kessel AD, Suijkerbuijk RF. Fluorescence in situ hybridization analysis of chromosome 12 anomalies in semen cells from patients with carcinoma in situ of the testis. J Pathol 1998; 186: 235–9.
   Google Scholar
• Salanova M, Gandidni L, Lenzi A, Chiarenza C, Filippini A, Dondero F, et al. Is hyperdiploidy of immature ejaculated germ cells predictive of testis malignancy? Lab Invest 1999; 79: 1127–35.
   PubMed Web of Science ®Google Scholar
• Skakkebwk NE. Carcinoma in situ of the testis: fre-quency and relationship to invasive germ cell tumours in infertile men. Histopathology 1978; 2: 157–70.
   PubMed Web of Science ®Google Scholar
• Schiitte B. Early testicular cancer in severe oligozoos-permia. In: Holstein AF, Leidenberger F, Holzer KH, Bettendorf G, eds. Carl Schirren Symposium: Advances in andrology. Berlin: Diesbach Verlag, 1988: 188–90.
   Google Scholar
• Nistal M, Code sal J, Paniagua R. Carcinoma in situ of the testis in infertile men. A histological, immunocyto-chemical, and cytophotometric study of DNA content. J Pathol 1989; 159: 205–10.
   Google Scholar
• Bettocchi C, Coker CB, Deacon J, Parkinson C, Pryor JP. A review of testicular intratubular germ cell neoplasia in infertile men. J Androl 1994; 5 (Suppl): 14S–16S.
   Google Scholar
• Zorn B, Virant-Klun I, Sinkovec J, Vraspir-Porent O, Meden-Vrtovec H. Carcinoma in situ of the testis in infertile men. Experience in a medically assisted reproduction program. Contracept Fertil Sex 1999; 27: 41–6 (in French).
   PubMedGoogle Scholar
• Giwereman A, Thomsen JK, Hertz J, Berthelsen JG, Jensen V, Meinecke B, et al. Prevalence of carcinoma in situ of the testis in 207 oligozoospermic men from infertile couples: prospective study of testicular biop-sies. Br Med J 1997; 315: 989–91.
   PubMed Web of Science ®Google Scholar
• Moller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case-control study. Br Med J 1999; 318: 559–62.
   PubMed Web of Science ®Google Scholar
• Sigg C, Hedinger C. Atypical germ cells in testicular biopsy in male sterility. Int J Androl 1981; (Suppl 4): 163–71.
   Google Scholar
• Mougharbel S, Aftimos G, Ghosn S. Carcinome in situ du testicule (CIST). A propos de 7 cas. J Urol (Paris) 1990; 96: 25–9.
   Google Scholar
• Rogers E, Teahan S, Gallagher H, Butler MR, Grainger R, McDermott TE, et al. The role of orchiectomy in the management of postpubertal cryptorchidism. J Urol 1998; 159: 851–4.
   PubMed Web of Science ®Google Scholar
• Giwereman A, Bruun E, Frimodt-Moller C, Skakke-baek NE. Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 1989; 142: 998–1001.
   Google Scholar
• Ford TF, Parkinson MC, Pryor JP. The undescended testis in adult life. Br J Urol 1985; 57: 181–4.
   Google Scholar
• Pedersen KV, Boiesen P. Zetterlund CG. Experience of screening for carcinoma-in-situ of the testis among young men with surgically corrected maldescended testes. Int J Androl 1987; 10: 181–5.
   Google Scholar
• Homak M, Pauer M, Bardos AJ, Ondrus D. The inci-dence of carcinoma in situ in postpubertal undescended testis. Int Urol Nephrol 1987; 19: 321–5.
   PubMedGoogle Scholar
• Radojkovic M, Ilic S. Carcinoma in situ in cryptorchid testes in post-pubertal patients. Vojnosanit Pregl 1992; 49: 493–7 (in Serbo-Croat).
   PubMedGoogle Scholar
• Cortes D, Visfeldt J, Moller H, Thorup J. Testicular neoplasia in cryptorchid boys at primary surgery: case series. Br Med J 1999; 319: 888–9.
   PubMed Web of Science ®Google Scholar
• Williams JC, Merguerian PA, Schned AR, Amdur RJ. Bilateral testicular carcinoma in situ in persistent mullerian duct syndrome: a case report and literature review. Urology 1994; 44: 595–8.
   PubMed Web of Science ®Google Scholar
• Armstrong GR, Buckley CH, Kelsey AM. Germ cell expression of placental alkaline phosphatase in male pseudohermaphroditism. Histopathology 1991; 18: 541–7.
   Google Scholar
• Muffly KE, McWhorter CA, Bartone FF, Gardner PJ. The absence of premalignant changes in the cryptorchid testis before adulthood. J Urol 1984; 131: 523–5.
   PubMed Web of Science ®Google Scholar
• Hadziselimovic F, Hecker E, Herzog B. The value of testicular biopsy in cryptorchidism. Urol Res 1984; 12: 171–4.
   Google Scholar
• Parkinson MC, Swerdlow AJ, Pike MC. Carcinoma in situ in boys with cryptorchidism: when can it be detected? Br J Urol 1994; 73: 431–5.
   Google Scholar
• Dieckmann K-P, Loy V, Buttner P. Prevalence of bilateral testicular germ-cell tumours and early detec-tion based on contralateral testicular intra-epithelial neoplasia. Br J Urol 1993; 71: 340–5.
   Google Scholar
• Hoff Wanderas E, Fossa SD, Tretli S. Risk of a second germ cell cancer after treatment of a primary germ cell cancer in 2201 Norwegian male patients. Eur J Cancer 1997; 33: 244–52.
   Google Scholar
• Osterlind A, Berthelsen JG, Abildgaard N, Hansen SO, Hjalgrim H, Johansen B, et al. Risk of bilateral testicular germ cell cancer in Denmark: 1960-1984. J Natl Cancer Inst 1991; 83: 1391–5.
   PubMed Web of Science ®Google Scholar
• von der Maase H, Giwereman A, Miller J, Skakkebaek NE. Management of carcinoma-in-situ of the testis. Int J Androl 1987; 10: 209–20.
   PubMedGoogle Scholar
• Dieckmann K-P, Loy V. Prevalence of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell neoplasms. J Clin Oncol 1996; 14: 3126–32.
   Google Scholar
• Holstein AF, Lauke H. Histologic diagnostics of early testicular germ-cell tumor. Int J Urol 1996; 3: 165–72.
   PubMedGoogle Scholar
• Klein FA, Melamed MR, Whitmore WFJ. Intratubular malignant germ cells (carcinoma in situ) accompanying invasive testicular germ cell tumors. J Urol 1985; 133: 413–5.
   Google Scholar
• Walz PH, Eitner S, Tan HK, Bohm E. Häufig,keit und Verteilungsmuster des Carcinoma in situ in tumor-befallenen Hoden. Akt Urol 1992; 23: 73–7.
   Web of Science ®Google Scholar
• Pottek T, Lauke H, Hartmann M. Carcinoma in situ in testes with germ cell tumour. Adv Exp Med Biol 1997; 424: 79–80.
   PubMed Web of Science ®Google Scholar
• Houlgatte A, Fournier R, Camparo P. de la Taille A, Berlizot P. Houdelette P. Value of detection of carcinoma in situ in conservative surgery of germ cell tumors of the testis. Prog Urol 1998; 8: 1039–42 (in French).
   Google Scholar
• Daugaard G, Wirth M, von der Maase H, Skakkebaek NE. Management of extragonadal germ-cell tumors and the significance of bilateral testicular biopsies. Ann Oncol 1992; 3: 283–9.
   Google Scholar
• Mile A, Studer UE, Sonntag RW, Scheidegger JR. Primary or secondary extragonadal germ cell tumours? J Urol 1986; 135: 939–43.
   PubMed Web of Science ®Google Scholar
• Hailemariam S, Engeler DS, Bannwart F, Amin MB. Primary mediastinal germ cell tumor with intratubular germ cell neoplasia of the testis-further support for germ cell origin of these tumors: a case report. Cancer 1997; 79: 1031–6.
   PubMed Web of Science ®Google Scholar
• Dueland S, Stenwig AE, Heilo A, Hoie J, Ous S, Fossa SD. Treatment and outcome of patients with extra-gonadal germ cell tumours-the Norwegian Radium Hospital's experience 1979-1994. Br J Cancer 1998; 77: 329–35.
   PubMed Web of Science ®Google Scholar
• Giwereman A, Muller J, Skakkebaek NE. Prevalence of carcinoma in situ and other histopathological abnor-malities in testes from 399 men who died suddenly and unexpectedly. J Urol 1991; 145: 77–80.
   Google Scholar
• Dieckmann K-P, Skakkebaek NE. Carcinoma in situ of the testis: A review of biological and clinical features. Int J Cancer 1999; 83: 815–22.
   Google Scholar
• Skakkebwk NE, Berthelsen JG, Muller J. Carcinoma in situ of the undescended testis. Urol Clin N Am 1982; 9: 377–85.
   PubMed Web of Science ®Google Scholar
• Daugaard G, Giwereman S, Skakkebaek NE. Should the other testis be biopsied? Semin Urol Oncol 1996; 14: 8–12.
   PubMedGoogle Scholar
• Dieckmann K-P, Loy V. The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: the recent German experience. APMIS 1998; 106: 13–20,20-3.
   Google Scholar
• Giwereman A, von der Maase H, Berthelsen JG, Rorth M, Bertelsen A, Skakkebaek NE. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 1991; 73: 596–603.
   PubMed Web of Science ®Google Scholar
• Mumperow E, Lauke H, Holstein AF, Hartmann M. Further practical experiences in the recognition and management of carcinoma in situ of the testis. Urol Int 1992; 48: 162–6.
   PubMed Web of Science ®Google Scholar
• Dieckmann K-P, Besserer A, Loy V. Low-dose radiation therapy of testicular intraepithelial neoplasia. J Cancer Res Clin Oncol 1993; 119: 355–9.
   Google Scholar
• Weissbach L. Organ preserving surgery of malignant germ cell tumors. J Urol 1995; 153: 90–3.
   PubMed Web of Science ®Google Scholar
• Heidenreich A, Holtl W, Albrecht W, Pont J, Engel-mann UH. Testis-preserving surgery in bilateral testicular germ cell tumours. Br J Urol 1997; 79: 253–7.
   Google Scholar
• Petersen PM, Giwereman A, Hansen SW, Berthelsen JG, Daugaard G, Wirth M, Skakkebaek NE. Impaired testicular function in patients with carcinoma-in-situ of the testis. J Clin Oncol 1999; 17: 173–9.
   Google Scholar
• Fossa SD, Opjordsmoen S, Haug E. Androgen replace-ment and quality of life in patients treated for bilateral testicular cancer. Eur J Cancer 1999; 35: 1220–5.
   Google Scholar
• Herr HVV, Bar-chama N, O'Sullivan M, et al. Paternity in men with stage I testis tumor on surveillance. J Clin Oncol 1998; 16: 733–4.
   PubMed Web of Science ®Google Scholar
• Fordham MW, Mason MD, Blackmore C, et al. Management of the contralateral testis in patients with testicular germ cell cancer. Br J Urol 1990; 65: 290–3.
   PubMedGoogle Scholar
• Dieckmann K-P, Loy V. Paternity of a patient with testicular seminoma and contralateral testicular intra-epithelial neoplasia. Int J Androl 1993; 16: 143–6.
   Google Scholar
• Kliesch S, Bergmann M, Hertle L, Nieschlag E, Behre HM. Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum Reprod 1997; 12: 2830–5.
   Google Scholar
• Heidenreich A, Vorreuther R, Neubauer S, Zumbe J, Engelmann UH. Paternity in patients with bilateral testicular germ cell tumours. Eur Urol 1997; 31: 246–8.
   Google Scholar
• Houlgatte A, DeLa Taile A, Fournier R, et al. Paternity in a patient with seminoma and carcinoma in situ in a solitary testis treated by partial orchiectomy. Br J Urol 1999; 84: 374.
   Google Scholar
• Christensen TB, Daugaard G, Geertsen PF, von der Maase H. Effect of chemotherapy on carcinoma in situ of the testis. Ann Oncol 1998; 9: 657–60.
   Google Scholar
• Dieckmann K-P, Loy V. Intratesticular effects of cisplatin-based chemotherapy. Eur Urol 1995; 28: 25–30.
   Google Scholar
• SEER Cancer Statistics Review. The Surveillance, Epidemiology and End Results (SEER) Program of The National Cancer Institute, USA (updates available on the Internet)..
   Google Scholar
• European Database of the International Agency for Research on Cancer (IARC), Lyon, France (updates available on the Internet).
   Google Scholar